CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer
Mengjiao Han1, Dongjun Dai1, Neelum Aziz Yousafzai1
1Department of Medical Oncology, Sir Run Run Shaw Hospital, Medical School of Zhejiang University, Hangzhou, China.
Abstract:
Worldwide, gastric cancer is one of the most fatal cancers. Epigenetic alterations in gastric cancer play important roles in silencing of tumor suppressor genes. We previously found that CXXC finger protein 4 (CXXC4) was a novel tumor suppressor in gastric cancer. In this report, we demonstrated that CXXC4 inhibited growth of gastric cancer cells as a pro-apoptotic factor. This inhibition could be reversed by the pan-caspase inhibitor called Z-VAD-FMK. However, CXXC4 with mutations in its DNA binding domain failed to induce apoptosis. Growth differentiation factor 15 (GDF15) was identified as one of potential targets responsible for CXXC4-induced apoptosis. CXXC4 activated GDF15 transcription through enhancing the interaction of transcription factor Sp1 with GDF15 promoter. In summary, the nuclear protein CXXC4 activated apoptosis in gastric cancer through up-regulating its novel potential downstream target GDF15. GDF15 might be a promising target for clinical treatment of gastric cancer with CXXC4 deficiency.
Insights
Nuclear protein CXXC4 acts as a tumor suppressor in gastric cancer by inducing apoptosis. It up-regulates Growth Differentiation Factor 15 (GDF15), a potential therapeutic target for gastric cancer.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Gastric cancer is a leading cause of cancer mortality globally.
- Epigenetic modifications are crucial in gastric cancer pathogenesis, often silencing tumor suppressor genes.
- CXXC finger protein 4 (CXXC4) was previously identified as a novel tumor suppressor in gastric cancer.
Purpose of the Study:
- To elucidate the mechanism by which CXXC4 functions as a tumor suppressor in gastric cancer.
- To investigate the role of CXXC4 in apoptosis induction and identify its downstream targets.
- To explore the therapeutic potential of targeting CXXC4 or its downstream effectors.
Main Methods:
- Cell-based assays to assess CXXC4's effect on gastric cancer cell growth and apoptosis.
- Use of pan-caspase inhibitor Z-VAD-FMK to confirm caspase-dependent apoptosis.
- Mutation analysis of CXXC4's DNA binding domain to assess its role in apoptosis induction.
- Reporter assays and chromatin immunoprecipitation to identify and validate GDF15 as a downstream target and elucidate the transcriptional regulation mechanism.
Main Results:
- CXXC4 significantly inhibited gastric cancer cell growth by acting as a pro-apoptotic factor.
- The pro-apoptotic effect of CXXC4 was dependent on caspase activity and the integrity of its DNA binding domain.
- Growth differentiation factor 15 (GDF15) was identified as a key downstream target, with CXXC4 enhancing GDF15 transcription via Sp1 interaction with the GDF15 promoter.
Conclusions:
- CXXC4 induces apoptosis in gastric cancer cells through up-regulation of its novel downstream target, GDF15.
- GDF15 represents a promising therapeutic target for gastric cancer, particularly in cases with CXXC4 deficiency.
More Related Videos
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Apoptosis


